Quarterly report pursuant to Section 13 or 15(d)

Equity (Details) - Schedule of summary of stock option activity

v3.23.1
Equity (Details) - Schedule of summary of stock option activity
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Schedule of Summary of Stock Option Activity [Abstract]  
Number of Shares Outstanding, Beginning balance | shares 3,396,000
Weighted Average Exercise Price Outstanding, Beginning balance | $ / shares $ 8
Weighted Average Remaining Contractual Term (in years) Outstanding, Beginning balance 8 years 10 months 6 days
Aggregate Intrinsic Value Outstanding, Beginning balance | $ $ 15,204
Number of Shares, Granted | shares 11,000
Weighted Average Exercise Price, Granted | $ / shares $ 10.89
Number of Shares, Exercised | shares (1,000)
Weighted Average Exercise Price, Exercised | $ / shares $ 7
Number of Shares, Cancelled | shares (82,000)
Weighted Average Exercise Price, Cancelled | $ / shares $ 5.76
Number of Shares Outstanding, Ending balance | shares 3,324,000
Weighted Average Exercise Price Outstanding, Ending balance | $ / shares $ 8.07
Weighted Average Remaining Contractual Term (in years) Outstanding, Ending balance 8 years 6 months
Aggregate Intrinsic Value Outstanding, Ending balance | $ $ 11,114
Number of Shares, Exercisable | shares 975,000
Weighted Average Exercise Price, Exercisable | $ / shares $ 13.66
Weighted Average Remaining Contractual Term (in years), Exercisable 7 years 2 months 15 days
Aggregate Intrinsic Value, Exercisable | $ $ 2,304